Treatments

MRD Testing for Acute Lymphoblastic Leukemia

An expert explains the importance of measurable residual disease (MRD) testing, and how it can inform treatment decisions.

Andrew Schorr, Susan M. O'Brien, MD

Kids with ALL Tolerate CAR T-Cell Therapy Better than Adults

Kids with acute lymphoblastic leukemia (ALL) often tolerate CAR T-cell therapy better than adults. Find out why.

Latest News

CAR T-Cell Therapy Gives Hope to Children with Blood Cancers

Multi-Agent Therapies for Acute Lymphoblastic Leukemia

Gail J. Roboz, MD, Ruth Fein

Treating Adult, Adolescent and Pediatric Acute Lymphoblastic Leukemia (ALL)

Gail J. Roboz, MD, Ruth Fein

Current Treatments for Adult Acute Lymphoblastic Leukemia

Gail J. Roboz, MD, Ruth Fein

Acute Lymphoblastic Leukemia Treatment During Coronavirus Outbreak

Gail J. Roboz, MD, Ruth Fein

Immunotherapy and Chemotherapy for Pediatric ALL

Andrew Schorr, Allison Grimes, MD

Acute Lymphoblastic Leukemia in Children Versus Adults

Lauren Evoy Davis

Confidence in Your Care: A Team Approach to Treating ALL

Jud Logan, Andrew Schorr, Hetty Carraway, MD

Treatments for ALL: Chemo and Beyond

Ryan Cassaday, MD, Andrew Schorr

The Science Behind Immunotherapy for ALL

Patrick Brown, MD, Esther Schorr

Antibodies, Immunotherapy and Clinical Trials

Shira Dinner, MD, Esther Schorr

Do ALL Treatments Depend on Age?

Esther Schorr, Patrick Brown, MD